Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Tecar Therapy (Targeted Radiofrequency Therapy) on Pain, Physical Function, and Physical Capacity in Patients With Chronic Knee Osteoarthritis: A Randomized Controlled Trial

NCT07438392 is registered in ClinicalTrials.gov with Kirsehir Ahi Evran Universitesi as lead sponsor.

NCT NCT07438392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07438392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Tecar Therapy (Targeted Radiofrequency Therapy) on Pain, Physical Function, and Physical Capacity in Patients With Chronic Knee Osteoarthritis: A Randomized Controlled Trial
Lead sponsor
Kirsehir Ahi Evran Universitesi
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
August 1, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteearthritis